Pharma Mar, S.A.
PHMMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,811 | $23,352 | -$3,904 | $9,545 |
| Dep. & Amort. | $2,359 | $1,996 | $1,986 | $2,129 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $98 | $67 | -$237 |
| Change in WC | $58,074 | -$25,560 | -$8,021 | -$12,180 |
| Other Non-Cash | -$36,045 | $9,263 | $3,588 | $2,434 |
| Operating Cash Flow | $19,576 | $9,149 | -$6,284 | $1,691 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,399 | -$1,421 | -$504 | -$1,402 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $195,772 | -$103,428 | -$67,706 | -$90,443 |
| Inv. Sales/Matur. | $0 | $78,040 | $79,525 | $111,850 |
| Other Inv. Act. | -$179,228 | $0 | $0 | $393 |
| Investing Cash Flow | $15,146 | -$26,809 | $11,315 | $20,398 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,471 | -$179 | $678 | -$470 |
| Stock Issued | -$2,318 | $1,240 | $735 | $16,265 |
| Stock Repurch. | $2,367 | -$6,690 | -$7,738 | -$8,527 |
| Dividends Paid | $0 | -$13,949 | $0 | $0 |
| Other Fin. Act. | $35 | -$471 | -$486 | -$3,053 |
| Financing Cash Flow | -$2,387 | -$20,049 | -$6,811 | $4,215 |
| Forex Effect | $581 | -$990 | -$1,167 | $2,135 |
| Net Chg. in Cash | $32,916 | -$38,699 | -$2,947 | $28,439 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,436 | $60,292 | $63,239 | $34,800 |
| End Cash | $58,353 | $21,593 | $60,292 | $63,239 |
| Free Cash Flow | $18,178 | $7,728 | -$6,788 | -$206 |